Rating History for Cincor Pharma Inc (CINC) by Oppenheimer

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/29/2022 Jay Olson Downgrade Perform
(Outperform)
N/A
(N/A)
26.53
(29.06)
9.54% Details